secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATAI Life Sciences N.V. (—)
CIK:        0001840904
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001140361-23-048183
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ATAI CFO Stephen Bardin on parental leave; CAO Anne Johnson named interim CFO
-----------------------------------------------------------------------------

- CFO Stephen Bardin went on parental leave on October 10, 2023.
- Supervisory Board appointed Chief Accounting Officer Anne Johnson as Interim CFO effective October 13, 2023.
- Johnson will not receive additional compensation for the interim role.
- Upon Bardin's return, he will resume CFO duties and Johnson will return to CAO role.
- Johnson's biographical info and employment agreement were previously disclosed in Q1 2023 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840904/000114036123048183/0001140361-23-048183-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840904/000114036123048183/ef20012551_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-048183

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer